Stocks and Investing
Stocks and Investing
Wed, July 18, 2018
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tue, July 17, 2018
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Vincent Andrews Maintained (CC) at Hold with Decreased Target to $48 on, Jul 17th, 2018
Vincent Andrews of Morgan Stanley, Maintained "The Chemours Company" (CC) at Hold with Decreased Target from $58 to $48 on, Jul 17th, 2018.
Vincent has made no other calls on CC in the last 4 months.
There are 2 other peers that have a rating on CC. Out of the 2 peers that are also analyzing CC, 0 agree with Vincent's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Vincent
- PJ Juvekar of "Citigroup" Maintained at Strong Buy with Decreased Target to $64 on, Wednesday, July 11th, 2018
- John McNulty of "BMO Capital" Initiated at Buy and Held Target at $68 on, Wednesday, March 28th, 2018
Contributing Sources